NAYA Biosciences, Inc.
NAYA Biosciences, Inc. (NAYA) Revenue
Annual & quarterly revenue history · segment & region breakdown
NAYA · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsNAYA Biosciences, Inc. trailing twelve-month (TTM) revenue is $0.01B, an increase of 116.25% year-over-year from $0.01B in FY2024.
Revenue trend
2024 – 2006 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2024-12-31 | $0.01B | +$0.00B | +116.25% |
| 2023-12-31 | $0.00B | +$0.00B | +267.38% |
| 2022-12-31 | $0.00B | -$0.00B | -80.24% |
| 2021-12-31 | $0.00B | +$0.00B | +301.06% |
| 2020-12-31 | $0.00B | -$0.00B | -29.92% |
| 2019-12-31 | $0.00B | +$0.00B | +199.41% |
| 2018-12-31 | $0.00B | +$0.00B | +75.22% |
| 2017-12-31 | $0.00B | +$0.00B | +454.30% |
| 2016-12-31 | $0.00B | +$0.00B | +335.46% |
| 2015-12-31 | $0.00B | -$0.00B | -82.72% |
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income NAYA Biosciences, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
NAYA Biosciences, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from NAYA Biosciences, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
NAYA revenue · 4 questionsNAYA's trailing twelve-month (TTM) revenue is $0.01B. That is an increase of 116.25% year-over-year from $0.01B in FY2024.
▸ Source: FMP · NAYA Biosciences, Inc. SEC filings · GAAP · NAYA Biosciences, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026